The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Role of osteopontin in tumour progression
Open accessAbstract
Since its first identification as a transformation-associated protein, osteopontin (OPN) has been recognised as important in the processes of tumorigenicity and metastasis. Here, we review the evidence that OPN might be considered as a candidate prognostic marker in human cancer. In animal systems, evidence from cell injection experiments and genetically manipulated mice suggest an important but complex role for the protein in tumour progression. Moreover, studies in a variety of human cancers associate high levels of OPN expression in tumours or in blood with more advanced cancers. The mechanism of action of OPN in promoting cancer is still unclear, and we consider aspects of OPN biology that can complicate interpretation of human studies. Nevertheless, growing evidence supports a role for OPN as a potential prognostic factor for various human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Sodek, J., Ganss, B., & McKee, M. D. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110030101 · Cited by 993
NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival
Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., & Giachelli, C. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1083 · Cited by 485
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Kim, J.-H. (2002) · JAMA · doi:10.1001/jama.287.13.1671 · Cited by 480
Agrawal, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.513 · Cited by 413
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
Fedarko, N. S., Jain, A., Karadağ, A., Eman, M. R. V., & Fisher, L. W. (2001) · PubMed · Cited by 380
Role of Osteopontin in Cellular Signaling and Toxicant Injury
Denhardt, D. T., Giachelli, C. M., & Rittling, S. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.723 · Cited by 349
Self-citationCoppola, D., Szabo, M., Boulware, D., Muraca, P., Alsarraj, M., Chambers, A. F., & Yeatman, T. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1405-2 · Cited by 341
Self-citationOsteopontin expression and distribution in human carcinomas.
Brown, L. F., Papadopoulos-Sergiou, A., Berse, B., Manseau, E. J., Tognazzi, K., Perruzzi, C. A., Dvorak, H. F., & Senger, D. R. (1994) · PubMed Central · Cited by 329
Vargas-Roig, L. M., Gago, F. E., Tello, O. M., Aznar, J. C., & Ciocca, D. R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981023)79:5<502::aid-ijc10>3.0.co;2-3 · Cited by 302
Transformed mammalian cells secrete specific proteins and phosphoproteins
Senger, D. R., Wirth, D. F., & Hynes, R. O. (1979) · Cell · doi:10.1016/0092-8674(79)90103-x · Cited by 298
Singhal, H., Bautista, D., Tonkin, K. S., O’Malley, F. P., Tuck, A. B., Chambers, A. F., & Harris, J. F. (1997) · PubMed · Cited by 285
Self-citationPrognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., El‐Tanani, M., Rudland, S. D. S., Barraclough, R., Winstanley, J. H. R., Howitt, R., & West, C. R. (2002) · PubMed · Cited by 276
Pan, H., Ou, Y., Peng, S., Liu, S., Lai, P., Lee, P., Sheu, J., Chen, C., & Hsu, H. (2003) · Cancer · doi:10.1002/cncr.11487 · Cited by 251
The Functional and Clinical Roles of Osteopontin in Cancer and Metastasis
Furger, K. A., Menon, R. K., Tuck, A. B., Bramwell, V. H. C., & Chambers, A. F. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363339 · Cited by 217
Self-citationLe, Q., Sutphin, P. D., Raychaudhuri, S., Yu, S. C. T., Terris, D. J., Lin, H. S., Lum, B. L., Pinto, H. A., Koong, A. C., & Giaccia, A. J. (2003) · PubMed · Cited by 216
Aberrant function of the Ras signal transduction pathway in human breast cancer
Clark, G. J., & Der, C. J. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00694753 · Cited by 213
Senger, D. R., Perruzzi, C. A., Gracey, C. F., Papadopoulos, A., & Tenen, D. G. (1988) · PubMed · Cited by 200
Tuck, A. B., Arsenault, D., O’Malley, F. P., Hota, C., Ling, M. C., Wilson, S. M., & Chambers, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202799 · Cited by 191
Self-citationOsteopontin expression in lung cancer
Chambers, A. F., Wilson, S. M., Kerkvliet, N., O'Malley, F. P., Harris, J. F., & Casson, A. G. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00595-1 · Cited by 189
Self-citationYamamoto, N., Sakai, F., Kon, S., Morimoto, J., Kimura, C., Yamazaki, H., Okazaki, I., Seki, N., Fujii, T., & Uede, T. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17778 · Cited by 187
Zhu, B., Suzuki, K., Goldberg, H. A., Rittling, S. R., Denhardt, D. T., McCulloch, C. A. G., & Sodek, J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10394 · Cited by 172
Self-citationCrawford, H. C., Matrisian, L. M., & Liaw, L. (1998) · PubMed · Cited by 169
Hotte, S. J., Winquist, E. W., Stitt, L., Wilson, S. M., & Chambers, A. F. (2002) · Cancer · doi:10.1002/cncr.10709 · Cited by 161
Self-citationThe Role of Osteopontin in Breast Cancer: Clinical and Experimental Studies
Tuck, A. B., & Chambers, A. F. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1014734930781 · Cited by 160
Self-citationDas, R., Mahabeleshwar, G. H., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303445200 · Cited by 158
Tuck, A. B., Elliott, B. E., Hota, C., Tremblay, E., & Chambers, A. F. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20000901)78:3<465::aid-jcb11>3.0.co;2-c · Cited by 145
Self-citationTuck, A. B., Hota, C., Wilson, S. M., & Chambers, A. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206209 · Cited by 128
Self-citationOsteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Leali, D., Dell’Era, P., Stabile, H., Sennino, B., Chambers, A. F., Naldini, A., Sozzani, S., Nico, B., Ribatti, D., & Presta, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1085 · Cited by 126
Self-citationDenhardt, D., Mistretta, D., Chambers, A., Krishna, S., Porter, J., Raghuram, S., & Rittling, S. (2004) · Clinical and Experimental Metastasis · doi:10.1023/a:1022550721404 · Cited by 115
Self-citationOsteopontin Deficiency Reduces Experimental Tumor Cell Metastasis to Bone and Soft Tissues
Nemoto, H., Rittling, S. R., Yoshitake, H., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.4.652 · Cited by 111
Self-citationUrquidi, V., Sloan, D. D., Kawai, K., Agarwal, D., Woodman, A., Tarin, D., & Goodison, S. (2002) · PubMed · Cited by 102
Osteopontin is required for full expression of the transformed phenotype by the ras oncogene
Wu, Y., Denhardt, D. T., & Rittling, S. R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1200 · Cited by 93
Self-citationOsteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
Médico, E., Gentile, A., Celso, C. L., Williams, T. A., Gambarotta, G., Trusolino, L., & Comoglio, P. M. (2001) · PubMed · Cited by 75
Bautista, D. S., Saad, Z., Chambers, A. F., Tonkin, K. S., O’Malley, F. P., Singhal, H., Tokmakejian, S., Bramwell, V. H. C., & Harris, J. F. (1996) · Clinical Biochemistry · doi:10.1016/0009-9120(96)84728-a · Cited by 64
Self-citationWang‐Rodriguez, J., Urquidi, V., Rivard, A. L., & Steve Goodison, B. (2003) · Breast Cancer Research · doi:10.1186/bcr620 · Cited by 47
Feng, F., & Rittling, S. R. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006466516192 · Cited by 29
Self-citationChang, P., Cao, M., & Hicks, P. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg138 · Cited by 28
Chen, Y., & Rittling, S. R. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022675031185 · Cited by 20
Self-citation
Cited by
Osteopontin: role in cell signaling and cancer progression
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.005 · Cited by 735
Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease
Aslam, M., Baveja, R., Liang, O. D., Fernandez-Gonzalez, A., Lee, C., Mitsialis, S. A., & Kourembanas, S. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0242oc · Cited by 508
Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin
McAllister, S. S., Gifford, A. M., Greiner, A. L., Kelleher, S. P., Saelzler, M. P., Ince, T. A., Reinhardt, F., Harris, L. N., Hylander, B. L., Repasky, E. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.045 · Cited by 431
Caswell, P. T., Chan, M., Lindsay, A. J., McCaffrey, M. W., Boettiger, D., & Norman, J. C. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200804140 · Cited by 388
Ma, L., Wang, L., Khatib, S. A., Chang, C.-W., Heinrich, S., Dominguez, D. A., Forgues, M., Candia, J., Hernandez, M. O., Kelly, M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.06.028 · Cited by 373
Metadata
- Authors
- Rittling, S. R., & Chambers, A. F.
- Venue
- British Journal of Cancer
- Published
- 2004-04-27
- Volume
- 90
- Issue
- 10
- Pages
- 1877-1881
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2132378346
- Cited by
- 413
- References
- 40
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.